Keyword: Bayer

Researchers scoured the database where pharma companies disclose payments made to physicians and discovered a troubling trend.

After Lilly’s Cyramza flopped a liver cancer trial in 2014, the company designed a trial for a specific subpopulation. Now, it’s back with a win.

Following a big finish in the fourth quarter, Bristol-Myers' CEO took home a 10% pay raise for 2017 to $18.7 million. 

Bayer is struggling with more than just sales in its consumer health unit. It's now contending with the second Alka-Seltzer recall in less than a year.

A judge has ordered 1,200 Xarelto liability cases against J&J and Bayer to be prepared for trial in courts around the country.

Bayer CEO Werner Baumann admitted the company isn't doing enough to keep up with U.S. consumers' rapid shift toward buying health products online.

Bayer's Monsanto deal hasn't even closed yet, and healthcare sales are already showing cause for concern.

Repeated drug price hikes have caught plenty of criticism lately, but the attention isn't dissuading everyone.

The FDA has issued a warning letter to a Bayer finished products plant in Germany, where it says poor cleaning led to product cross-contamination.

The same day that Bristol-Myers Squibb reported a closely watched clinical win, the drugmaker announced Street-beating results.